Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
GC Pharma Receives Korea's MFDS Approval of GCFLU Quadrivalent (Influenza Vaccine) for persons 6 months and older
2018-10-01 12:18
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
2018-09-30 11:00
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody Sintilimab as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer
2018-09-30 11:00
First Patient Dosed in a Phase III Trial of Anti-PD-1 Antibody Sintilimab as First-line Treatment for Patients with Advanced Squamous Non-Small Cell Lung Cancer
2018-09-30 11:00
Innovent Receives an Approval from the US FDA to Initiate Clinical Trials for its Anti-CD47 Monoclonal Antibody IBI-188
2018-09-30 11:00
China SXT Pharmaceuticals, Inc. Announces Effectiveness of Registration Statement on Form F-1 and Pricing the Initial Public Offering of its Ordinary Shares at $4.00 per Share
2018-09-29 05:15
Discover How to Create Value for MedTech Stakeholders in Frost & Sullivan's Webinar
2018-09-28 22:56
NeuroAiD combined with rehabilitation has shown additive and sustained benefits on post-stroke recovery over 2 years after an initial 3-month treatment following stroke onset
2018-09-28 21:00
LYNCH Biologics Closes on Transaction to Purchase GEM 21S® Growth Factor Enhanced Matrix for Dental Bone Regeneration
2018-09-28 20:00
JLK Inspection with AI Technologies at Radiological Society of North America 2018 and International Security Expo 2018
2018-09-28 19:13
New Phase 2 Data for Somapacitan Demonstrate Its Potential as an Efficacious Once-weekly Treatment for Childhood Growth Hormone Deficiency
2018-09-28 14:40
World Health Organization, St. Jude Children's Research Hospital collaborate against childhood cancer
2018-09-27 21:00
National Comprehensive Cancer Network Moves Global Headquarters to Plymouth Meeting, PA
2018-09-27 20:00
Medix survey uncovers Hong Kong's fear and confusion around cancer
2018-09-27 18:33
The 2nd International Chinese Medicine Cultural Festival presents "Chinese Medicine without Frontier" documentary screening tour
2018-09-27 13:33
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody™ Platform for Three Bispecific Antibody Programs
2018-09-26 21:27
I-Mab Biopharma Expands Strategic Collaboration with WuXi Biologics and Licenses WuXiBody(TM) Platform for Three Bispecific Antibody Programs
2018-09-26 19:24
Celebrating Innovators, Leaders and Business Winners in Asia's Pharma Market
2018-09-26 11:00
Ganovo Enrolled in the Basic Medical Insurance of Tianjin--Capped Reimbursement-Per-Patient Pilot Program
2018-09-26 06:30
Medix Medical Monitor Survey Uncovers Singapore's Health Concerns and Perceptions
2018-09-25 23:26
1
691
692
693
694
695
970